Search research articles
Contact Us
Filters
Showing results (141-150 of 146) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 146 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 3, 2005
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin
J-L Pujol, J-L Breton, R Gervais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer
J von Pawel, J H Schiller, F A Shepherd, et al.
Revue Des Maladies Respiratoires
|
May 24, 2007
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]
V Westeel, M P Lebitasy, M Mercier, et al.
British Journal of Cancer
|
August 14, 2003
Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)
A Depierre, J L Lagrange, S Theobald, et al.
Bulletin Du Cancer
|
May 24, 2001
[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma]
E Bardet, D Moro-Sibilot, T Le Chevalier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 28, 2001
[Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy]
E Touboul, J L Lagrange, S Theobald, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 146) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 146 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 3, 2005
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin
J-L Pujol, J-L Breton, R Gervais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer
J von Pawel, J H Schiller, F A Shepherd, et al.
Revue Des Maladies Respiratoires
|
May 24, 2007
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]
V Westeel, M P Lebitasy, M Mercier, et al.
British Journal of Cancer
|
August 14, 2003
Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)
A Depierre, J L Lagrange, S Theobald, et al.
Bulletin Du Cancer
|
May 24, 2001
[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma]
E Bardet, D Moro-Sibilot, T Le Chevalier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 28, 2001
[Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy]
E Touboul, J L Lagrange, S Theobald, et al.
Page
of 15